Comparison

AGILENT TECHNOLOGIES, INC. (A) vs Twist Bioscience Corp (TWST)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

AGILENT TECHNOLOGIES, INC.

Diagnostics & Research

Revenue, FY25: $6.95B
Net income: -
Operating cash flow: $1.56B
Free cash flow: $1.15B
Net margin: -
Operating margin: 21.29%
Gross margin: 52.43%

TWST

Twist Bioscience Corp

Diagnostics & Research

Revenue, FY25: $377M
Net income: −$77.67M
Operating cash flow: −$47.63M
Free cash flow: −$75.63M
Net margin: −20.63%
Operating margin: −36.18%
Gross margin: 50.72%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	A	TWST
Revenue growth, latest filed year	+6.73%	+20.32%
Piotroski F-score	2 of 5	4 of 8
P/E against its own history	-	-

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

Currency moves
Tariffs
Tax
Data privacy
Export controls
Debt covenants

And 18 more.

TWST

Litigation
Commodity prices
FDA approval
Key people
Cybersecurity
Export controls

And 19 more.

Tracked managers holding both

Joel Greenblatt Gotham Asset Management 0.08% · 0.00%

Updated Sep 8, 2026 · the newer of the two companies' filings